{
    "Trade/Device Name(s)": [
        "TBI Flex\u00ae reagent cartridge",
        "DBI Flex\u00ae reagent cartridge",
        "TBI/DBI Calibrator",
        "Dade Behring Dimension Total and Direct Bilirubin Assays"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K060628",
    "Predicate Device Reference 510(k) Number(s)": [
        "K861700",
        "K862359"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIG",
        "JIS"
    ],
    "Summary Letter Date": "April 6, 2006",
    "Summary Letter Received Date": "March 9, 2006",
    "Submission Date": "March 8, 2006",
    "Regulation Number(s)": [
        "21CFR862.1110",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system",
        "Bilirubin Calibrator"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Bilirubin",
        "Direct Bilirubin",
        "Ditauro-bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae clinical chemistry system"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric (diazo chemistry)"
    ],
    "Methodologies": [
        "Endpoint bichromatic absorbance measurement"
    ],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Dade Behring Dimension Total and Direct Bilirubin reagent cartridges and calibrator using photometric diazo chemistry for quantitative measurement in serum and plasma.",
    "Indications for Use Summary": "Quantitative measurement of total and direct bilirubin in human serum and plasma for diagnosis and treatment of liver, hemolytic, hematological, and metabolic disorders, including hepatitis and gallbladder disease; calibrator intended for use with Dimension\u00ae system methods.",
    "fda_folder": "Clinical Chemistry"
}